Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

David A. Qualls, Nicholas Lambert,Paolo F. Caimi,Mwanasha Merrill,Priyanka Pullarkat,Richard C. Godby,David A. Bond,Graham T. Wehmeyer,Jason Romancik,Behzad Amoozgar,Lori Leslie,Loretta J. Nastoupil,Jennifer L. Crombie,Jeremy S. Abramson,Arushi Khurana,Grzegorz S. Nowakowski,Kami Maddocks,Sarah C. Rutherford,Brad Kahl,Michelle Okwali,Michael J. Buege,Venkatraman Seshan,Connie L. Batlevi,Gilles Salles

BLOOD（2023）

Cited 1|Views25
No score
Abstract
In this real-world evaluation of tafasitamab-lenalidomide (TL) in relapsed/refractory LBCL, patients receiving TL had higher rates of comorbidities and high-risk disease characteristics, and substantially lower progression-free survival and overall survival, compared to the L-MIND registration clinical trial for TL.
More
Translated text
Key words
lymphoma,lenalidomide,real-world
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined